Livagen 20mg

Livagen (also known as KEDA or Lys-Glu-Asp-Ala) is a synthetic tetrapeptide bioregulator from the same family of short regulatory peptides as Epithalon. Research has focused on its potential roles in chromatin remodeling, ribosomal gene activity, lymphocyte function, and age-related cellular decline.

Chemical Makeup Molecular Formula: C18H31N5O9 | Molecular Weight: 461.47 g/mol | Also known as: KEDA, Lys-Glu-Asp-Ala

Research Highlights

• Chromatin Decondensation — Studies in lymphocyte cultures from elderly subjects suggest Livagen may promote decondensation of heterochromatin, potentially reactivating genes silenced by age-related chromatin compaction.
• Gene Expression — Research indicates the peptide may activate ribosomal genes and increase nucleolar organizer region activity — markers associated with protein-synthesis capacity that typically declines with age.
• Immune Cell Activity — Studies suggest Livagen may influence lymphocyte differentiation and proliferation, with reported increases in the proportion of cells expressing activation markers.
• Tissue Specificity — As a member of the Khavinson short-peptide bioregulator family, Livagen has been investigated for tissue-directed activity rather than broad systemic action.
• Cellular Aging — Research has examined the peptide in cell-culture models of senescence, where short peptide bioregulators are proposed to act through direct interaction with DNA.

Available for research and laboratory purposes only.